fbpx

Laser Eye Surgery of Erie

What is Macular Degeneration?

Age-related macular degeneration (AMD) is a deterioration or breakdown of the eye’s macula. The macula is a small area in the retina — the light-sensitive tissue lining the back of the eye. The macula is the part of the retina that is responsible for your central vision, allowing you to see fine details clearly.

Symptoms associated with age-related macular degeneration include:

  • A gradual loss of ability to see objects clearly
  • A gradual loss of color vision
  • Distorted vision
  • A dark or empty area appearing in the center of the vision

Vision loss is usually gradual, patients who develop macular degeneration must carefully and constantly monitor their central vision. Our experienced team is equipped to administer specialized treatments and care. Regular exams are the best way to detect the disease and inform your ophthalmologist of any vision changes. 

Laser eye surgery of erie

Types of macular degeneration

Dry Macular Degeneration

Dry macular degeneration is the most common form. In its early stages, the thinning and aging of the macula will lead to excess pigment development which collects in small deposits in the tissues of the eye. Patients in their early to mid stages of dry macular degeneration may have blind spots in the center of their vision. In advanced stages, patients may lose their central vision completely. Advanced dry AMD is also known as geographic atrophy.

There is some good news for patients with AMD and geographic atrophy.  A new injection for eyes with geographic atrophy has been approved as of February 2023 called Pegcetacoplan (Syfovre®).  This injection targets the “Complement System.”   The injection specifically targets the complement factor C3.  This blocks the inflammatory cascade which can ultimately damage your macula and cause decreased or poor vision.  Pegcetacoplan (Syfovre®) injection is recommended to be given every one to two months.  Insurance approval is pending and some insurances will take longer for approval than others.

For more information regarding Pegcetacoplan (Syfovre®) go to https://syfovre.com/

Wet Macular Degeneration

Wet macular degeneration occurs when abnormal blood vessels begin to grow and form in the eye, causing blood and fluid to leak out and damage the cells in the retina which respond to light.  Vision loss from this form of macular degeneration may be faster and more noticeable than that from dry macular degeneration.

The longer these abnormal vessels leak or grow, the more risk you have of losing more of your detailed vision. If abnormal blood vessel growth happens in one eye, there is a risk that it will occur in the other eye. The earlier that wet macular degeneration is diagnosed and treated, the better chance you have of preserving your central vision.

Treatment for Wet Macular Degeneration

For some patients, a laser procedure may be used to treat their wet macular degeneration. For most, injections will be recommended.

Avastin®, Eylea®, Lucentis®, and Vabysmo® are intravitreal injections given to treat wet macular degeneration.  These medications have helped millions of patients worldwide.  Early and consistent injections can help prevent vision loss.  These injections will need to be repeated every one to two months.

For more information regarding Avastin® for the treatment of wet age-related macular degeneration, visit http://www.nih.gov/news/health/apr2012/nei-30a.htm.

For more information regarding Eylea® for the treatment of wet age-related macular degeneration, visit http://www.eylea.us.

For more information regarding Lucentis® for the treatment of wet age-related macular degeneration, visit http://www.lucentis.com.

For more information regarding Vabysmo® for the treatment of wet age-related macular degeneration, visit http://www.vabysmo.com

 

laser eye surgery of erie

Additional Services